The following dose-escalation schema of 8 levels will be used: 0.5, 1.0, 1.5,
2.0, 2.5, 3.5, 4.5, and 6.0 mg/m2 EC1456 (with further 25% increments if MTD
is not reached). One would expect safety issue but there is none so far. Next dose is 2.5mg. If they can safely administer maximum dose this drug could create billions.
Buying will come gradually, I cant stress the fact the CEO clearly mention that couple patients failed all prior treatment staying almost 9 months in on EC1456 and no safety issue. These are some early indicator of new breakthrough in this science. It is a jackpot but not overnight. After couple of quarters this should be around 15$. Long term you can think of REGN, PBYI..